You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
Two months before the 11 September terrorist attacks, an independent panel of experts concluded that the military's system for developing vaccines to protect troops from anthrax, smallpox, and other exotic bioweapons "is insufficient and will fail." The report, sources tell Science, may lead to a sweeping overhaul of how the federal government develops vaccines to protect both the military and civilians from bioweapons. But developing a new suite of vaccines presents difficult scientific challenges, and testing the safety and effectiveness of preparations against lethal diseases that aren't already widespread will be problematic.
